From: Somatic mutation spectrum of a Chinese cohort of pediatrics with vascular malformations
Variable | N, (%) | Molecular diagnosis rate, N (%) |
---|---|---|
Total | 67 | 53 (79.1) |
Sex | Â | Â |
 Male | 33 (47.8) | 24 (72.7) |
 Female | 34 (52.2) | 29 (85.3) |
Median age, years | 2.3 | – |
 IQR | 0.7–6.0 | – |
 Range | 0.1–14.8 | – |
Age distribution | Â | Â |
 <1 year | 21 (31.3) | 16 (76.2) |
 1–3 years | 17 (25.4) | 15 (88.2) |
 3–10 years | 22 (34.3) | 18 (81.8) |
    >10 years | 7 (9.0) | 4 (57.1) |
Diagnosis | Â | Â |
 CLOVES | 4 (6.0) | 4 (100) |
 KTS | 15 (22.4) | 14 (93.3) |
 uPROS | 1 (1.5) | 1 (100) |
 DCMO | 3 (4.5) | 0 (0) |
 CLVM | 6 (9.0) | 5 (83.3) |
 CLM | 2 (3.0) | 1 (50.0) |
 LM | 1 (1.5) | 1 (100) |
 CMO | 7 (10.4) | 6 (85.7) |
 PWS | 12 (17.9) | 10 (83.3) |
 SWS | 2 (3.0) | 2 (100) |
 VM | 6 (9.0) | 5 (83.3) |
 VVM | 7 (10.4) | 3 (42.9) |
Proteus syndrome | 1 (1.5) | 1 (100) |